The Latest Trump Move Involving Minneapolis Is Going to Trigger a Lib Meltdown
Here’s Why That ICE Agent Involved in the Minneapolis Shooting Is in Hiding
Latest NYT Piece on Mamdani Shows How Being an American Liberal Is Just...
Why the Hell Should We Care If Democrats Don’t?
Israel Misunderstood
A Quick Bible Study Vol. 303: The Best of St. Paul
You're Gonna Need a Hazmat Suit to Listen to These Leftist Podcast Clips
Leftists Storm Minneapolis Church Hunting Alleged ICE Agent
Swalwell Vows to Punish ICE Officers If He Wins Governor's Seat
Iran’s Spiritual Revolution
Frey: Let Minneapolis Get Back to Running Daycares
You Won't Believe What These Hotels Are Doing to ICE Agents
Trump Questions Why Minnesotans Are Harassing ICE, Civilians
Men Need to Work
Greenland and the Return of Great-Power Politics
Tipsheet

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

President Biden on Monday nominated Dr. Monica Bertagnolli, a surgical oncologist and head of the National Cancer Institute, to be the next director of the National Institutes of Health, but critics say the White House left out an important detail about her background in the administration’s announcement.  

Advertisement

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said in a statement.
 
“As Director of the National Cancer Institute, Dr. Bertagnolli has advanced my Cancer Moonshot to end cancer as we know it. She has brought together partners and resources from different sectors to launch groundbreaking efforts in cancer prevention and early detection, a national navigation program for childhood cancers, and additional programs to bring clinical trials to more Americans,” the statement continued. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.” 

As Democratic presidential candidate Robert F. Kennedy Jr. and others pointed out, she’s a “revolving door” nominee. 

“From 2015-2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her. research grants,” he tweeted. 

Kennedy was sure to point out this doesn’t automatically make her “personally corrupt,” but that she will champion Big Pharma’s viewpoints.  

Advertisement

“That is how agencies are captured,” he added, commenting later that he was not surprised the White House left this detail out of the announcement. 


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement